HPGDS and asthma: In a Phase II study that employed an experimental RV challenge of patients with asthma, DP2 antagonism did not affect exacerbation severity and of note, the investigators reported a negative correlation between PGD2 levels during RV infection and prescribed ICS dose35, consistent with the notion that steroids decrease the effectiveness of DP2 antagonism.